Provided by Tiger Trade Technology Pte. Ltd.

Reneo Pharmaceuticals, Inc.

18.20
0.0000
Volume:- -
Turnover:794.64K
Market Cap:60.84M
PE:-10.81
High:18.20
Open:18.20
Low:18.20
Close:18.20
52wk High:18.20
52wk Low:0.9801
Shares:3.34M
Float Shares:1.10M
Volume Ratio:- -
T/O Rate:- -
Dividend:- -
Dividend Rate:- -
EPS(TTM):-1.6843
EPS(LYR):-2.5227
ROE:-54.00%
ROA:-33.72%
PB:0.79
PE(LYR):-7.21

Loading ...

Company Profile

Company Name:
Reneo Pharmaceuticals, Inc.
Exchange:
NASDAQ
Establishment Date:
- -
Employees:
- -
Office Location:
- -
Zip Code:
- -
Phone:
- -
Fax:
- -
Introduction:
Reneo Pharmaceuticals, Inc., a clinical-stage pharmaceutical company, focuses on the development and commercialization of therapies for patients with rare genetic mitochondrial diseases. Its lead product candidate is REN001, a potent and selective agonist of the peroxisome proliferator-activated receptor delta that is in clinical development for genetic mitochondrial diseases comprising primary mitochondrial myopathies and long-chain fatty acid oxidation disorders. Reneo Pharmaceuticals, Inc. was incorporated in 2014 and is headquartered in Irvine, California.